Family Office Of America (FOFA) Cash & Equivalents (2021 - 2026)
Family Office Of America (FOFA) posted Cash & Equivalents of $343220.0 for Q1 2026, up 120.3% sequentially from $155798.0 in Q4 2025, and down 39.28% YoY from $565222.0 in Q1 2025.
Family Office Of America (FOFA) Cash & Equivalents (2021 - 2026) Analysis & Trends
Family Office Of America has reported Cash & Equivalents for 6 years, with the latest figure at $343220.0 in Q1 2026.
- Quarterly Cash & Equivalents fell 39.28% year-over-year to $343220.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $343220.0 (down 39.28% YoY) and the FY2025 annual result came in at $155798.0, up 1046.75% from the prior year.
- Cash & Equivalents grew to $343220.0 in Q1 2026 per FOFA's latest filing, from $155798.0 in the prior quarter.
- Over five years, Cash & Equivalents peaked at $827598.0 in Q3 2025 and troughed at $1331.0 in Q3 2023.
- A 5-year average of $211882.6 and a median of $90571.0 in 2024 frame the typical range for Cash & Equivalents.
- The sharpest annual moves came in 2023 and 2024: Cash & Equivalents tumbled 99.23% in 2023, then soared 3408.94% in 2024.
- Over 5 years, Cash & Equivalents stood at $69858.0 in 2022, then sank by 96.52% to $2431.0 in 2023, then jumped by 458.86% to $13586.0 in 2024, then jumped by 1046.75% to $155798.0 in 2025, then surged by 120.3% to $343220.0 in 2026.
- According to Business Quant data, Cash & Equivalents over the past three periods registered $343220.0, $155798.0, and $827598.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.95 Bn | 193.35 Bn | 7.27 Bn | 5.10 Bn |
| 2 | Stryker | 128.10 Bn | 124.63 Bn | 4.50 Bn | 3.39 Bn |
| 3 | Medtronic | 118.91 Bn | 109.69 Bn | 6.41 Bn | 1.95 Bn |
| 4 | Boston Scientific | 73.43 Bn | 72.89 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.91 Bn | 47.66 Bn | 1.35 Bn | 2.91 Bn |
| 6 | Dexcom | 34.52 Bn | 32.58 Bn | 830.00 Mn | 1.11 Bn |
| 7 | GE HealthCare Technologies | 33.94 Bn | 31.83 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.37 Bn | 23.05 Bn | 4.55 Bn | 3.25 Bn |
| 9 | Steris | 23.14 Bn | 22.66 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Family Office Of America | 27.84 Mn | 27.20 Mn | 532,674.00 | 636,887.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 343,220.00 |
| Dec 31, 2025 | 155,798.00 |
| Sep 30, 2025 | 827,598.00 |
| Jun 30, 2025 | 585,273.00 |
| Mar 31, 2025 | 565,222.00 |
| Dec 31, 2024 | 13,586.00 |
| Sep 30, 2024 | 46,704.00 |
| Jun 30, 2024 | 62,956.00 |
| Mar 31, 2024 | 90,571.00 |
| Dec 31, 2023 | 2,431.00 |
| Sep 30, 2023 | 1,331.00 |
| Jun 30, 2023 | 24,627.00 |
| Mar 31, 2023 | 16,105.00 |
| Dec 31, 2022 | 69,858.00 |
| Sep 30, 2022 | 171,952.00 |
| Jun 30, 2022 | 226,287.00 |
| Mar 31, 2022 | 398,485.00 |
| Dec 31, 2021 | 528,284.00 |
| Sep 30, 2021 | 703,921.00 |
| Jun 30, 2021 | 1.06 Mn |